Cargando…

Pneumococcal Antibody Titers: A Comparison of Patients Receiving Intravenous Immunoglobulin Versus Subcutaneous Immunoglobulin

Purpose: Immunoglobulin replacement is the mainstay treatment in patients with humoral immunodeficiencies, yet a handful of patients continue to develop sinopulmonary infections while on therapy. The objective of our study was to compare immunoglobulin G (IgG) pneumococcal antibody levels in patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abghari, Pamella F., Poowuttikul, Pavadee, Secord, Elizabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347419/ https://www.ncbi.nlm.nih.gov/pubmed/28321436 http://dx.doi.org/10.1177/2333794X16689639

Ejemplares similares

Poor Adherence With Medication Refill and Medical Supplies Maintenance as Risk Factors for Inpatient Asthma Admission in Children
por: Poowuttikul, Pavadee, et al.
Publicado: (2017)

Anti A/B Antibody Titer Rebound: Are we Making it Worse? Be Aware of Your Intravenous Immunoglobulin
por: Kher, A., et al.
Publicado: (2018)

Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies
por: Canessa, Clementina, et al.
Publicado: (2016)

Scleromyxedema with Subcutaneous Nodules: Successful Treatment with Thalidomide and Intravenous Immunoglobulin
por: Dolenc-Voljč, M., et al.
Publicado: (2013)

Is It Safe to Switch From Intravenous Immunoglobulin to Subcutaneous Immunoglobulin in Patients With Common Variable Immunodeficiency and Autoimmune Thrombocytopenia?
por: Scheuerlein, Philipp, et al.
Publicado: (2018)

Therapeutic Immunoglobulin Selected for High Antibody Titer to RSV also Contains High Antibody Titers to Other Respiratory Viruses
por: Orange, Jordan S., et al.
Publicado: (2015)

Pemphigoid gestationis and intravenous immunoglobulin therapy()
por: Yang, Anes, et al.
Publicado: (2018)

Trough Concentrations of Specific Antibodies in Primary Immunodeficiency Patients Receiving Intravenous Immunoglobulin Replacement Therapy
por: Hassin, Ori, et al.
Publicado: (2021)

INTRAVENOUS IMMUNOGLOBULIN IN DERMATOLOGY
por: Dhar, Sandipan
Publicado: (2009)

Detection of Antibodies Against Human Leukocyte Antigen Class II in the Sera of Patients Receiving Intravenous Immunoglobulin
por: Takamatsu, Hiroyuki, et al.
Publicado: (2021)

Subcutaneous Immunoglobulin for Antibody Deficiency in Antineutrophil Cytoplasmic Antibody (ANCA)-associated Vasculitis
por: Kant, Sam, et al.
Publicado: (2019)

New Frontiers in Subcutaneous Immunoglobulin Treatment
por: Jolles, Stephen, et al.
Publicado: (2011)

Use of subcutaneous immunoglobulin in inflammatory myositis
por: Zhou, Alan L, et al.
Publicado: (2021)

Intrathecal Administration of High-Titer Cytomegalovirus Immunoglobulin for Cytomegalovirus Meningitis
por: Fujiwara, Shin-ichiro, et al.
Publicado: (2014)

Economic benefits of subcutaneous rapid push versus intravenous immunoglobulin infusion therapy in adult patients with primary immune deficiency
por: Martin, A, et al.
Publicado: (2013)

Economic benefit of subcutaneous rapid push versus intravenous immunoglobulin infusion therapy in adult patients with primary immune deficiency
por: Martin, Adriana, et al.
Publicado: (2012)

Antifungal antibodies present in intravenous immunoglobulin derived from China
por: Wang, Yanfang, et al.
Publicado: (2023)

Implications to payers of switch from hospital-based intravenous immunoglobulin to home-based subcutaneous immunoglobulin therapy in patients with primary and secondary immunodeficiencies in Canada
por: Gerth, William C, et al.
Publicado: (2014)

Safety, efficiency, and treatment satisfaction in children with primary immunodeficiency receiving subcutaneous immunoglobulin treatment
por: Eltan, Sevgi Bilgic, et al.
Publicado: (2022)

Successful ABO-incompatible living donor liver transplantation using splenectomy and intravenous immunoglobulin in high isoagglutinin titer patients
por: Lee, Boram, et al.
Publicado: (2020)

A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency
por: Visentin, Andrea, et al.
Publicado: (2022)

Deficit of Anterior Pituitary Function and Variable Immune Deficiency Syndrome: A Novel Mutation
por: Poowuttikul, Pavadee, et al.
Publicado: (2017)

Pollen Allergy Screening with Allergen-Specific and Total Immunoglobulin E Titers
por: Yokoi, Hidenori, et al.
Publicado: (2022)

Efficacy of Glucocorticoid plus Intravenous Immunoglobulin in Children with Immunoglobulin-Insensitive Kawasaki Disease
por: Ma, Yongmei, et al.
Publicado: (2022)

Hyaluronidase facilitated subcutaneous immunoglobulin in primary immunodeficiency
por: Jolles, Stephen
Publicado: (2013)

Immunological evidence and regulatory potential for cell-penetrating antibodies in intravenous immunoglobulin
por: Sali, Aggeliki D, et al.
Publicado: (2015)

Early intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with onconeural antibodies
por: Berzero, Giulia, et al.
Publicado: (2018)

Assessment of antibody levels to SARS-CoV-2 in patients with idiopathic inflammatory myopathies receiving treatment with intravenous immunoglobulin
por: Bae, Sangmee Sharon, et al.
Publicado: (2023)

Intravenous Immunoglobulin in the Management of Lupus Nephritis
por: Wenderfer, Scott E., et al.
Publicado: (2012)

Intravenous Immunoglobulin for Overwhelming Postsplenectomy Infection
por: Nakamura, Kensuke, et al.
Publicado: (2021)

Intravenous Immunoglobulin: Revisited – My Experience
por: Vaishampayan, Sanjeev S., et al.
Publicado: (2021)

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
por: Talaei, M., et al.
Publicado: (2021)

Intravenous immunoglobulin for the treatment of Kawasaki disease
por: Broderick, Cathryn, et al.
Publicado: (2023)

Intravenous immunoglobulins versus plasma exchange in the treatment of Guillain-Barré syndrome
por: Charra, B, et al.
Publicado: (2009)

Treatment costs associated with hospital-based intravenous immunoglobulin therapy compared to home-based subcutaneous immunoglobulin therapy in a cohort of paediatric patients with primary immunodeficiency
por: Ducruet, Thierry, et al.
Publicado: (2011)

Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection
por: Ben-Nathan, David, et al.
Publicado: (2009)

Clinical response to therapeutic plasmapheresis and intravenous immunoglobulin in pregnancies complicated by alloimmunization despite persistently high titers: Report of two cases
por: Bahkali, Nedaa, et al.
Publicado: (2023)

Hyper IgE syndrome‐related disease treated with dupilumab: A case report
por: Kao, Andrew S., et al.
Publicado: (2023)

Retracted: Efficacy of Glucocorticoid plus Intravenous Immunoglobulin in Children with Immunoglobulin-Insensitive Kawasaki Disease
por: Healthcare Engineering, Journal of
Publicado: (2023)

Ten-year population trends of immunoglobulin use, burden of adult antibody deficiency and feasibility of subcutaneous immunoglobulin (SCIg) replacement in Hong Kong Chinese
por: Kan, Andy Ka Chun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m8jqcdpk9bfp5gvmf0feg2ni4d